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Abstract 
 
We report a rare case of altered mental status in a young patient with immature ovarian teratoma. A 22-year-old 
woman presented with seizures, hallucination, amnesia and orofacial dyskinesia. Examination and investigation 
revealed an ovarian massand asalphing-oophorectomy was performed. The histopathological examination result 
showed an immature teratoma grade 2 with thepresence of immature primitive glial tissue. Her CSF N-Methyl-D-
Aspartic acid receptor (Anti-NMDAR) antibodytest was positive. N-Methyl-D-Aspartic acid receptor antibody 
associated limbic encephalitis is an autoimmune antibody-mediated neuropsychiatric disorder. Resection of the 
tumour and immunotherapy resulted in full recovery. 
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Introduction 
 
Anti N-Methyl-D-Aspartate (NMDA) receptor 
encephalitis is a unique entity that described 
asyndromewith acute onset of psychiatric symptoms 
and neurologicalassociation with ovarian teratoma. 
Despite the fact that it has been recognized for past 
few decades, the cause is still not well understood. It is 
however seen more common in young women (1). We 
report a case of anti-NMDA receptor encephalitis with 
immature teratoma and illustrate the importance of 
early diagnosis and prompt surgical removal of tumour 
that resulted in a full recovery. 
 
Case Report 
 
A previously healthy 22-year-old Chinese female had 
developed fever and myalgia after jungle trekking a 
week before admission. There was no known history 
of drug or alcohol used before. She was brought to 
hospital after an episode of generalized tonic-clonic 
seizure. Her vital signs were stable and clinical 
examination was unremarkable. Urine toxicology was 
negative and an urgent CT brain imaging did not 
reveal any abnormality.  Her cerebrospinal fluid (CSF) 
pressure was normal and analysis revealed normal 
level glucose and protein. CSF investigation with 
Indian ink was negative and bacterial culture yielded 
no growth. Screening for viral encephalitis, blood 
culture and mycoplasma serology were negative. The 
initial provisional diagnosis of meningoencephalitis 
was made and she was started on intravenous (IV) 
ceftriaxone and acyclovir. She was also given 
anticonvulsant drugs, diazepam and phenytoin. 
 
After two days, she started to have myoclonic jerk at 
her lips and upper limbs. She was prescribed for oral 
levetiracetam 250mg twice daily. Apart from this, she 
experienced auditory hallucinations. She was thought 
to have a non-epileptic attack disorder as her seizure 
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semiology was atypical, consisting of bilateral upper 
limbs waving movement with preserved 
consciousness. Her EEG recording was normal at this 
point. A psychiatric team evaluation further assessed 
her to have ongoing personality vulnerability.  
 
Subsequently, she had another two episodes of 
generalized tonic clonic seizures. Her antiepileptic 
medications were changed to oral sodium valproate 
400mg twice daily and intravenous levetiracetam 
500mg twice daily. A second EEG was done and 
revealed slowing at the right hemisphere with epileptic 
discharges at right temporal lobe. She was noticed to 
have orofacial dyskinesia affecting her left face. She 
was then treated for limbic encephalitis and started on 
pulsed intravenous methylprednisolone 500mg daily 
for 3 days, and followed by oral prednisolone. 
 
Investigation for malignancy with MRI brain was 
unremarkable. However a lower abdominal mass was 
also noted clinically at that point. A transabdominal 
ultrasound revealed a cystic pelvis mass and a CT scan 
of the abdomen pelvis confirmed a complex cystic 
pelvic mass, arising from right ovary with no evidence 
of distant metastasis. Her tumuor markers revealed 
slight elevation in CA 19-9 and Alfa-Fetoprotein, 
results as follows: CA 19-9 149 U/mL (N: <37), Alfa-
Fetoprotein 15.71 ng/mL (N: 0.00-6.72), CA 125 34 
U/mL (N: 0-35), CEA 1.5 ng/mL (N: 0-3.0), Beta-
hCG<1.2 mIU/mL (N: <5.0). Autoimmune screening 
was negative. However, the N-Methyl-D-Aspartic acid 
receptor antibody test then showed a positive result. 
 
On day 15 of admission, she underwent a right 
salpingo-oophorectomy for the right ovarian teratoma.  
Intraoperative, the right ovarian mass was fully 
occupied by a smooth solid cystic tumour measuring 
around 10cm x 8cm and contained hair and sebum 
material (Fig. 1). The histopathological examination 
result showed ovarian immature teratoma grade 2 with 
the presence of immature primitive glial tissue.  
 
Six hours postoperation, she had an episode of acute 
delirium with laughing and crying that resolved after 5 
mg of Haloperidol. The following day, she had mild 
grade fever and was started on antibiotics for 
postoperative nosocomial infections. Despite this 
intervention, she developed blepharospasm and a kinetic 
mutism, followed by fine tremors, bradykinesia and 
mask-like facies. Hence, she was started on intravenous 
immunoglobulin 0.4 mg/kg/day for 5 days. A week 
later, patient became more responsive, seizures and 
psychosis behaviour subsided. Furthermore, hypomimia 
and bradykinesia have also improved. She was 
discharged home well with tapering dose of oral 
prednisolone, levetiracetam and sodium valproate.  
 
 
Figure 1: Right ovarian immature teratoma 
 
She underwent four cycles of chemotherapy and 
remained asymptomatic with no recurrence of ovarian 
cyst. Neurologically she had no more seizures or 
dyskinesia and had recovered her cognitive function. 
Her steroid was tapered off after one year. 
Nevertheless, she had amnesia and was unable to 
recall the entire event. Her final complete diagnosis 
was paraneoplastic anti-NMDAR encephalitis 
secondary to immature teratoma. 
 
Discussion 
 
Anti-NMDAR encephalitis was first reported by 
Dalmau et al. (2) almost a decade ago. Following that, 
several reports were published where majority of cases 
had mature ovarian teratoma (3) unlike immature 
teratoma found in this case.  Other tumours include 
small cells lung cancer (4), mediastinal tumours (1), 
bilateral testicular teratoma and seminoma in males 
(5). Lebas et al. (6) reported another interesting case of 
a young boy presented with anti-NMDAR encephalitis 
due to neuroblastoma. Anti-NMDAR encephalitis 
during pregnancy had been reported as well (7). 
 
The exact pathogenesis remained unknown. Prodromal 
symptoms may result from part of an early immune 
activation or the immune response across blood-brain 
barrier (4). It was postulated that ectopic expression of 
NR2 subunit-related antibodies by the nervous tissue 
content with some forming rosette in the teratoma 
contribute to reducing immune tolerance. Hence, 
formation of autobodies against NMDA receptor in the 
brain causes paraneoplastic neurologic syndrome (8). 
The fact that, this patient presented with neurological 
symptoms, psychiatric changes and not with 
gynaecological symptoms had put the priority of her 
gynaecology problem last.  
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Patients commonly present at their first and second 
decade of life with the mean age of 24 years old, a 
perfect timing for this patient (3). Clinical symptoms 
of anti-NMDAR encephalitis include prodromal 
symptoms mimicking flu and headache then followed 
by abnormal involuntary movements of facial muscles, 
seizures, cognitive problem and psychosis (1,4). Due 
to low suspicion of encephalitis, with the presence of 
ovarian tumour, majority of the cases had an extended 
time lapse between diagnosis and surgery. A review by 
Acién et al. (3) showed that the median time to surgery 
was 71.4 ± 88.5 days. On contrary in this current 
patient, she was treated for neurological and 
psychiatric problems first before realizing that there 
was a link with her ovarian mass. To date, there is no 
established guideline to specifically address its 
management. 
 
Majority of reviews suggested early detection and 
removal of teratoma resulted in a better outcome (1, 
3). Imaging studies such as pelvic ultrasound 
computed tomography and MRI are useful in 
screening for an ovarian teratoma. Hayashi et al. 
reported a 7mm ovarian teratoma was detected via 
MRI examination which had resulted in a successful 
laparoscopic resection (9). A review from Japan by 
Iizuka et al. (10) had reported a spontaneous recovery 
even without tumour removal. On contrary death had 
been reported due to delay in diagnosis of tumour (3, 
11,12). A few reports also showed that clinical 
improvement with blind ovariectomy despite negative 
imaging which later revealed an occult teratoma 
(13,14,15). In this patient a right salpingo-
oophorectomy was performed as the tumour was big. 
 
Teratoma is the most common ovarian germ cell 
tumuor and also the most common ovarian neoplasm 
in patients younger than 20 years old (16). 
Nevertheless in a patient with teratoma without any 
neurological symptoms, systemic screening of anti-
NMDAR antibodies is not warranted (17). A review of 
100 cases of anti-NMDAR encephalitis by Dalmau et 
al. (4) showed that 75 % recovered or had a mild 
deficit while the remaining had severe deficit or 
passed away. In the present case, the patient remained 
asymptomatic without recurrence for one year, until 
today.   
 
Conclusion  
 
Association of ovarian mass with anti-NMDAR 
encephalitis has long been detected. Nevertheless, the 
association is not always obvious clinically during the 
working diagnosis.  A clinician should consider anti-
NMDAR encephalitis in a young patient presenting 
with encephalitis of uncertain etiology and geared 
towards diagnostic work up with pelvic imaging for 
ovarian masses to ensure timely treatment. 
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